Phase 2a Study of the CCR5 Monoclonal Antibody PRO 140 Administered Intravenously to HIV-Infected Adults
Antimicrobial Agents and Chemotherapy - United States
doi 10.1128/aac.00086-10
Full Text
Open PDFAbstract
Available in full text
Date
July 26, 2010
Authors
Publisher
American Society for Microbiology